Published on
August 30, 2021
- 09:00 GMT
Tasrif Pharmaceutical Announces Grant of US Patent for Humanized Monoclonal Antibodies against the Poliovirus Receptor
USA, August 30, 2021 /EINPresswire.com/ -- Tasrif Pharmaceutical announces the grant of a US Patent related to its proprietary humanized monoclonal antibodies against the poliovirus receptor (a.k.a. CD155). The poliovirus receptor (PVR) is overexpressed …
Distribution channels:
Business & Economy, Companies
...
